COVID-19ACT () D-:III?

Ayşe Şahin Tutak1

  • 1Department of Internal Medicine Adıyaman University School of Medicine Adıyaman Turkey.

PubMed
概括

这份病例报告详细介绍了一名患有COVID-19和疑似抗血素III缺乏症的患者,呈现出严重的细胞因子风暴和高D-二次体水平,对肝素治疗没有反应. 它强调了诊断和管理非典型COVID-19病例的挑战.

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
837